Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy.
French Reference Center of Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, Lyon, France.
J Neurol. 2018 Mar;265(3):669-677. doi: 10.1007/s00415-018-8767-1. Epub 2018 Jan 30.
To identify the clinical and radiological features that should raise suspicion for the autoimmune encephalitis (AE)-like presentation of glioblastoma.
This is an observational, retrospective case series of patients referred to the French National Reference Center on Paraneoplastic Neurological Diseases for suspected AE (possible, probable or definite, using the 2016 criteria) who later received a final diagnosis of glioblastoma according to 2016 WHO criteria. An extensive literature search was also conducted for similar existing cases.
Between 2014 and 2016, 306 patients were referred to our center for suspected AE. Six of these patients (2%) later developed pathologically confirmed glioblastoma. Thirteen patients (9 male) were included for analysis (6 from the present series and 7 from the literature); median age was 63. Initially, a diagnosis of AE was clinically suspected based on: working memory deficits (77%), seizures (62%) (including status epilepticus in 23%), and psychiatric symptoms (46%). Initial brain MRI was not in favor of a typical glioblastoma pattern and showed bilateral (54%) or unilateral selective limbic involvement. Five patients exhibited initial slight contrast enhancement. A clear inflammatory CSF was present in five patients and three from the literature showed autoantibody positivity (NMDAR, VGKC, GluRepsilon2). Median delay between suspicions of AE to GBM diagnosis was 3 months (range 1.5-24) and one patient from the literature was diagnosed post-mortem.
An alternative diagnosis of glioblastoma should be considered in patients presenting initially as AE, especially in patients who do not fulfill the criteria for definite AE and in those with a poor clinical evolution despite initial improvement.
确定应引起疑似胶质母细胞瘤(GBM)自身免疫性脑炎(AE)样表现的临床和影像学特征。
这是一项观察性、回顾性病例系列研究,纳入了因疑似 AE(根据 2016 年标准为可能、很可能或明确 AE)而转至法国国家副肿瘤神经病学参考中心的患者,这些患者后来根据 2016 年 WHO 标准被诊断为 GBM。还对类似的现有病例进行了广泛的文献检索。
2014 年至 2016 年期间,有 306 名患者因疑似 AE 转至我们中心。其中 6 名患者(2%)后来被病理证实为 GBM。纳入 13 名患者(9 名男性)进行分析(6 名来自本系列,7 名来自文献);中位年龄为 63 岁。最初,根据以下表现临床怀疑为 AE:工作记忆障碍(77%)、癫痫发作(62%)(包括 23%的癫痫持续状态)和精神症状(46%)。初始脑 MRI 不支持典型 GBM 模式,表现为双侧(54%)或单侧选择性边缘系统受累。5 名患者表现出初始轻度增强。5 名患者中有明显的炎症性脑脊液,3 名来自文献的患者显示自身抗体阳性(NMDAR、VGKC、GluRepsilon2)。从怀疑 AE 到 GBM 诊断的中位时间为 3 个月(范围 1.5-24),文献中的 1 名患者为死后诊断。
对于最初表现为 AE 的患者,应考虑 GBM 的替代诊断,尤其是那些不符合明确 AE 标准且尽管最初有所改善但临床病情仍恶化的患者。